Versant Venture Capital VI, L.P. Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Versant Venture Capital VI, L.P..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Versant Venture Capital VI, L.P.. Versant Venture Capital VI, L.P. is 10% Owner in Black Diamond Therapeutics, Inc. ($BDTX) and 10% Owner in Oyster Point Pharma, Inc. ($OYST) and 10% Owner in Akero Therapeutics, Inc. ($AKRO) and 10% Owner in Aligos Therapeutics, Inc. ($ALGS) and 10% Owner in Pandion Therapeutics, Inc. ($PAND).
Latest Insider Trading Transactions of Versant Venture Capital VI, L.P.
Sentiment: All, AKRO, ALGS, BDTX, OYST, PAND
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 29 2020 | BDTX | Black Diamond Ther ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | J | 0.00 | 1,187 | 0 | 1,187 | 0 to 1.2 K |
Jul 29 2020 | BDTX | Black Diamond Ther ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | J | 0.00 | 1,187 | 0 | 1,187 | 0 to 1.2 K |
Jul 29 2020 | BDTX | Black Diamond Ther ... | Versant Venture Capital VI, L. ... | 10% Owner | Sell | J | 0.00 | 79,217 | 0 | 1,127,386 | 1.2 M to 1.1 M (-6.57 %) |
Jul 29 2020 | BDTX | Black Diamond Ther ... | Versant Venture Capital VI, L. ... | 10% Owner | Sell | J | 0.00 | 79,217 | 0 | 1,127,386 | 1.2 M to 1.1 M (-6.57 %) |
Jul 29 2020 | BDTX | Black Diamond Ther ... | Versant Venture Capital VI, L. ... | 10% Owner | Sell | J | 0.00 | 4,131 | 0 | 0 | 4.1 K to 0 (-100.00 %) |
Jul 29 2020 | BDTX | Black Diamond Ther ... | Versant Venture Capital VI, L. ... | 10% Owner | Sell | J | 0.00 | 4,131 | 0 | 0 | 4.1 K to 0 (-100.00 %) |
Jul 29 2020 | BDTX | Black Diamond Ther ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | J | 0.00 | 3,098 | 0 | 4,131 | 1 K to 4.1 K (+299.90 %) |
Jul 29 2020 | BDTX | Black Diamond Ther ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | J | 0.00 | 3,098 | 0 | 4,131 | 1 K to 4.1 K (+299.90 %) |
Jul 29 2020 | BDTX | Black Diamond Ther ... | Versant Venture Capital VI, L. ... | 10% Owner | Sell | J | 0.00 | 57,424 | 0 | 601,445 | 658.9 K to 601.4 K (-8.72 %) |
Jul 29 2020 | BDTX | Black Diamond Ther ... | Versant Venture Capital VI, L. ... | 10% Owner | Sell | J | 0.00 | 57,424 | 0 | 601,445 | 658.9 K to 601.4 K (-8.72 %) |
Jul 29 2020 | BDTX | Black Diamond Ther ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | J | 0.00 | 1,033 | 0 | 1,033 | 0 to 1 K |
Jul 29 2020 | BDTX | Black Diamond Ther ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | J | 0.00 | 1,033 | 0 | 1,033 | 0 to 1 K |
Jul 29 2020 | BDTX | Black Diamond Ther ... | Versant Venture Capital VI, L. ... | 10% Owner | Sell | J | 0.00 | 192,576 | 0 | 2,017,016 | 2.2 M to 2 M (-8.72 %) |
Jul 29 2020 | BDTX | Black Diamond Ther ... | Versant Venture Capital VI, L. ... | 10% Owner | Sell | J | 0.00 | 192,576 | 0 | 2,017,016 | 2.2 M to 2 M (-8.72 %) |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Versant Venture Capital VI, L. ... | 10% Owner | Option Exercise | C | 0.00 | 333,333 | 0 | 0 | |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Versant Venture Capital VI, L. ... | 10% Owner | Option Exercise | C | 0.00 | 1,245,330 | 0 | 0 | |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Versant Venture Capital VI, L. ... | 10% Owner | Option Exercise | C | 0.00 | 1,745,458 | 0 | 0 | |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Versant Venture Capital VI, L. ... | 10% Owner | Option Exercise | C | 0.00 | 14,452,795 | 0 | 0 | |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | C | 0.00 | 577,544 | 0 | 577,544 | 0 to 577.5 K |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | C | 0.00 | 3,176,507 | 0 | 3,176,507 | 0 to 3.2 M |
Feb 05 2020 | BDTX | Black Diamond Ther ... | Versant Venture Capital VI, L. ... | 10% Owner | Option Exercise | C | 0.00 | 2,444,382 | 0 | 0 | |
Feb 05 2020 | BDTX | Black Diamond Ther ... | Versant Venture Capital VI, L. ... | 10% Owner | Option Exercise | C | 0.00 | 1,055,960 | 0 | 0 | |
Feb 05 2020 | BDTX | Black Diamond Ther ... | Versant Venture Capital VI, L. ... | 10% Owner | Option Exercise | C | 0.00 | 314,873 | 0 | 0 | |
Feb 05 2020 | BDTX | Black Diamond Ther ... | Versant Venture Capital VI, L. ... | 10% Owner | Option Exercise | C | 0.00 | 1,370,833 | 0 | 0 | |
Feb 05 2020 | BDTX | Black Diamond Ther ... | Versant Venture Capital VI, L. ... | 10% Owner | Option Exercise | C | 0.00 | 1,517,940 | 0 | 0 | |
Feb 05 2020 | BDTX | Black Diamond Ther ... | Versant Venture Capital VI, L. ... | 10% Owner | Option Exercise | C | 0.00 | 452,630 | 0 | 0 | |
Feb 05 2020 | BDTX | Black Diamond Ther ... | Versant Venture Capital VI, L. ... | 10% Owner | Option Exercise | C | 0.00 | 1,970,572 | 0 | 0 | |
Feb 05 2020 | BDTX | Black Diamond Ther ... | Versant Venture Capital VI, L. ... | 10% Owner | Option Exercise | C | 0.00 | 3,851,526 | 0 | 0 | |
Feb 05 2020 | BDTX | Black Diamond Ther ... | Versant Venture Capital VI, L. ... | 10% Owner | Option Exercise | C | 0.00 | 1,148,474 | 0 | 0 | |
Feb 05 2020 | BDTX | Black Diamond Ther ... | Versant Venture Capital VI, L. ... | 10% Owner | Option Exercise | C | 0.00 | 15,000,000 | 0 | 0 | |
Feb 05 2020 | BDTX | Black Diamond Ther ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | P | 19.00 | 396,081 | 7,525,539 | 1,206,603 | 810.5 K to 1.2 M (+48.87 %) |
Feb 05 2020 | BDTX | Black Diamond Ther ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | P | 19.00 | 396,082 | 7,525,558 | 6,809,414 | 6.4 M to 6.8 M (+6.18 %) |
Feb 05 2020 | BDTX | Black Diamond Ther ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | P | 19.00 | 23,560 | 447,640 | 658,869 | 635.3 K to 658.9 K (+3.71 %) |
Feb 05 2020 | BDTX | Black Diamond Ther ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | P | 19.00 | 79,013 | 1,501,247 | 2,209,592 | 2.1 M to 2.2 M (+3.71 %) |
Feb 05 2020 | BDTX | Black Diamond Ther ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | C | 0.00 | 810,522 | 0 | 810,522 | 0 to 810.5 K |
Feb 05 2020 | BDTX | Black Diamond Ther ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | C | 0.00 | 350,141 | 0 | 2,130,579 | 1.8 M to 2.1 M (+19.67 %) |
Feb 05 2020 | BDTX | Black Diamond Ther ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | C | 0.00 | 104,407 | 0 | 635,309 | 530.9 K to 635.3 K (+19.67 %) |
Feb 05 2020 | BDTX | Black Diamond Ther ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | C | 0.00 | 454,548 | 0 | 6,413,332 | 6 M to 6.4 M (+7.63 %) |
Feb 05 2020 | BDTX | Black Diamond Ther ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | C | 0.00 | 503,327 | 0 | 1,780,438 | 1.3 M to 1.8 M (+39.41 %) |
Feb 05 2020 | BDTX | Black Diamond Ther ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | C | 0.00 | 150,085 | 0 | 530,902 | 380.8 K to 530.9 K (+39.41 %) |
Feb 05 2020 | BDTX | Black Diamond Ther ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | C | 0.00 | 653,412 | 0 | 5,958,784 | 5.3 M to 6 M (+12.32 %) |
Feb 05 2020 | BDTX | Black Diamond Ther ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | C | 0.00 | 1,277,111 | 0 | 1,277,111 | 0 to 1.3 M |
Feb 05 2020 | BDTX | Black Diamond Ther ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | C | 0.00 | 380,817 | 0 | 380,817 | 0 to 380.8 K |
Feb 05 2020 | BDTX | Black Diamond Ther ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | C | 0.00 | 4,973,787 | 0 | 5,305,372 | 331.6 K to 5.3 M (+1,500.00 %) |
Jan 21 2020 | AKRO | Akero Therapeutics ... | Versant Venture Capital VI, L. ... | 10% Owner | Sell | S | 22.39 | 17,849 | 399,639 | 3,092,698 | 3.1 M to 3.1 M (-0.57 %) |
Jan 21 2020 | AKRO | Akero Therapeutics ... | Versant Venture Capital VI, L. ... | 10% Owner | Sell | S | 21.78 | 8,091 | 176,222 | 3,110,547 | 3.1 M to 3.1 M (-0.26 %) |
Jan 21 2020 | AKRO | Akero Therapeutics ... | Versant Venture Capital VI, L. ... | 10% Owner | Sell | S | 20.09 | 11,103 | 223,059 | 3,118,638 | 3.1 M to 3.1 M (-0.35 %) |
Jan 21 2020 | AKRO | Akero Therapeutics ... | Versant Venture Capital VI, L. ... | 10% Owner | Sell | S | 19.72 | 22,489 | 443,483 | 3,129,741 | 3.2 M to 3.1 M (-0.71 %) |
Jan 15 2020 | AKRO | Akero Therapeutics ... | Versant Venture Capital VI, L. ... | 10% Owner | Sell | S | 19.73 | 7,511 | 148,192 | 3,152,230 | 3.2 M to 3.2 M (-0.24 %) |
Jan 15 2020 | AKRO | Akero Therapeutics ... | Versant Venture Capital VI, L. ... | 10% Owner | Sell | S | 19.73 | 7,511 | 148,192 | 3,152,230 | 3.2 M to 3.2 M (-0.24 %) |
Jan 15 2020 | AKRO | Akero Therapeutics ... | Versant Venture Capital VI, L. ... | 10% Owner | Sell | S | 20.00 | 12,307 | 246,140 | 3,159,741 | 3.2 M to 3.2 M (-0.39 %) |
Jan 15 2020 | AKRO | Akero Therapeutics ... | Versant Venture Capital VI, L. ... | 10% Owner | Sell | S | 20.00 | 12,307 | 246,140 | 3,159,741 | 3.2 M to 3.2 M (-0.39 %) |
Jan 15 2020 | AKRO | Akero Therapeutics ... | Versant Venture Capital VI, L. ... | 10% Owner | Sell | S | 20.84 | 83 | 1,730 | 3,172,048 | 3.2 M to 3.2 M (0.00 %) |
Jan 15 2020 | AKRO | Akero Therapeutics ... | Versant Venture Capital VI, L. ... | 10% Owner | Sell | S | 20.84 | 83 | 1,730 | 3,172,048 | 3.2 M to 3.2 M (0.00 %) |
Jan 15 2020 | AKRO | Akero Therapeutics ... | Versant Venture Capital VI, L. ... | 10% Owner | Sell | S | 20.16 | 11,593 | 233,715 | 3,172,131 | 3.2 M to 3.2 M (-0.36 %) |
Jan 15 2020 | AKRO | Akero Therapeutics ... | Versant Venture Capital VI, L. ... | 10% Owner | Sell | S | 20.16 | 11,593 | 233,715 | 3,172,131 | 3.2 M to 3.2 M (-0.36 %) |
Jan 15 2020 | AKRO | Akero Therapeutics ... | Versant Venture Capital VI, L. ... | 10% Owner | Sell | S | 20.10 | 19,343 | 388,794 | 3,183,724 | 3.2 M to 3.2 M (-0.60 %) |
Jan 15 2020 | AKRO | Akero Therapeutics ... | Versant Venture Capital VI, L. ... | 10% Owner | Sell | S | 20.10 | 19,343 | 388,794 | 3,183,724 | 3.2 M to 3.2 M (-0.60 %) |
Jan 09 2020 | AKRO | Akero Therapeutics ... | Versant Venture Capital VI, L. ... | 10% Owner | Sell | S | 20.21 | 16,527 | 334,011 | 3,203,067 | 3.2 M to 3.2 M (-0.51 %) |
Jan 09 2020 | AKRO | Akero Therapeutics ... | Versant Venture Capital VI, L. ... | 10% Owner | Sell | S | 19.80 | 22,368 | 442,886 | 3,219,594 | 3.2 M to 3.2 M (-0.69 %) |
Jan 09 2020 | AKRO | Akero Therapeutics ... | Versant Venture Capital VI, L. ... | 10% Owner | Sell | S | 20.05 | 14,162 | 283,948 | 3,241,962 | 3.3 M to 3.2 M (-0.43 %) |
Jan 06 2020 | AKRO | Akero Therapeutics ... | Versant Venture Capital VI, L. ... | 10% Owner | Sell | S | 19.93 | 42,323 | 843,497 | 3,256,124 | 3.3 M to 3.3 M (-1.28 %) |
Jan 06 2020 | AKRO | Akero Therapeutics ... | Versant Venture Capital VI, L. ... | 10% Owner | Sell | S | 18.32 | 6,101 | 111,770 | 3,298,447 | 3.3 M to 3.3 M (-0.18 %) |
Jan 06 2020 | AKRO | Akero Therapeutics ... | Versant Venture Capital VI, L. ... | 10% Owner | Sell | S | 17.68 | 4,968 | 87,834 | 3,304,548 | 3.3 M to 3.3 M (-0.15 %) |
Jan 06 2020 | AKRO | Akero Therapeutics ... | Versant Venture Capital VI, L. ... | 10% Owner | Sell | S | 20.27 | 100 | 2,027 | 3,309,516 | 3.3 M to 3.3 M (0.00 %) |
Jan 06 2020 | AKRO | Akero Therapeutics ... | Versant Venture Capital VI, L. ... | 10% Owner | Sell | S | 19.18 | 3,100 | 59,458 | 3,309,616 | 3.3 M to 3.3 M (-0.09 %) |
Jan 06 2020 | AKRO | Akero Therapeutics ... | Versant Venture Capital VI, L. ... | 10% Owner | Sell | J | 0.00 | 11,803 | 0 | 0 | 11.8 K to 0 (-100.00 %) |
Jan 06 2020 | AKRO | Akero Therapeutics ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | J | 0.00 | 11,803 | 0 | 11,803 | 0 to 11.8 K |
Jan 06 2020 | AKRO | Akero Therapeutics ... | Versant Venture Capital VI, L. ... | 10% Owner | Sell | J | 0.00 | 13,683 | 0 | 0 | 13.7 K to 0 (-100.00 %) |
Jan 06 2020 | AKRO | Akero Therapeutics ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | J | 0.00 | 13,683 | 0 | 13,683 | 0 to 13.7 K |
Jan 06 2020 | AKRO | Akero Therapeutics ... | Versant Venture Capital VI, L. ... | 10% Owner | Sell | J | 0.00 | 684,143 | 0 | 3,312,716 | 4 M to 3.3 M (-17.12 %) |
Jan 06 2020 | AKRO | Akero Therapeutics ... | Versant Venture Capital VI, L. ... | 10% Owner | Sell | S | 22.17 | 1,000 | 22,170 | 3,996,859 | 4 M to 4 M (-0.03 %) |
Jan 06 2020 | AKRO | Akero Therapeutics ... | Versant Venture Capital VI, L. ... | 10% Owner | Sell | S | 21.20 | 3,900 | 82,680 | 3,997,859 | 4 M to 4 M (-0.10 %) |
Jan 06 2020 | AKRO | Akero Therapeutics ... | Versant Venture Capital VI, L. ... | 10% Owner | Sell | S | 19.89 | 10,952 | 217,835 | 4,001,759 | 4 M to 4 M (-0.27 %) |
Dec 31 2019 | AKRO | Akero Therapeutics ... | Versant Venture Capital VI, L. ... | 10% Owner | Sell | S | 23.48 | 17,207 | 404,020 | 3,656,585 | 3.7 M to 3.7 M (-0.47 %) |
Dec 31 2019 | AKRO | Akero Therapeutics ... | Versant Venture Capital VI, L. ... | 10% Owner | Sell | S | 24.39 | 338,919 | 8,266,234 | 3,673,792 | 4 M to 3.7 M (-8.45 %) |
Dec 31 2019 | AKRO | Akero Therapeutics ... | Versant Venture Capital VI, L. ... | 10% Owner | Sell | S | 22.58 | 33,256 | 750,920 | 4,012,711 | 4 M to 4 M (-0.82 %) |
Dec 26 2019 | AKRO | Akero Therapeutics ... | Versant Venture Capital VI, L. ... | 10% Owner | Sell | S | 22.48 | 23,600 | 530,528 | 4,045,967 | 4.1 M to 4 M (-0.58 %) |
Dec 26 2019 | AKRO | Akero Therapeutics ... | Versant Venture Capital VI, L. ... | 10% Owner | Sell | S | 21.70 | 1,605 | 34,829 | 4,069,567 | 4.1 M to 4.1 M (-0.04 %) |
Dec 26 2019 | AKRO | Akero Therapeutics ... | Versant Venture Capital VI, L. ... | 10% Owner | Sell | S | 21.56 | 5,433 | 117,135 | 4,071,172 | 4.1 M to 4.1 M (-0.13 %) |
Dec 26 2019 | AKRO | Akero Therapeutics ... | Versant Venture Capital VI, L. ... | 10% Owner | Sell | S | 19.80 | 18,582 | 367,924 | 4,076,605 | 4.1 M to 4.1 M (-0.45 %) |
Dec 19 2019 | AKRO | Akero Therapeutics ... | Versant Venture Capital VI, L. ... | 10% Owner | Sell | S | 19.50 | 2,020 | 39,390 | 4,095,187 | 4.1 M to 4.1 M (-0.05 %) |
Dec 19 2019 | AKRO | Akero Therapeutics ... | Versant Venture Capital VI, L. ... | 10% Owner | Sell | S | 19.58 | 7,651 | 149,807 | 4,097,207 | 4.1 M to 4.1 M (-0.19 %) |
Dec 19 2019 | AKRO | Akero Therapeutics ... | Versant Venture Capital VI, L. ... | 10% Owner | Sell | S | 19.50 | 2,020 | 39,390 | 4,095,187 | 4.1 M to 4.1 M (-0.05 %) |
Dec 19 2019 | AKRO | Akero Therapeutics ... | Versant Venture Capital VI, L. ... | 10% Owner | Sell | S | 19.58 | 7,651 | 149,807 | 4,097,207 | 4.1 M to 4.1 M (-0.19 %) |
Nov 04 2019 | OYST | Oyster Point Pharm ... | Versant Venture Capital VI, L. ... | 10% Owner | Option Exercise | C | 0.00 | 566,158 | 0 | 0 | |
Nov 04 2019 | OYST | Oyster Point Pharm ... | Versant Venture Capital VI, L. ... | 10% Owner | Option Exercise | C | 0.00 | 495,388 | 0 | 0 | |
Nov 04 2019 | OYST | Oyster Point Pharm ... | Versant Venture Capital VI, L. ... | 10% Owner | Option Exercise | C | 0.00 | 1,941,500 | 0 | 0 | |
Nov 04 2019 | OYST | Oyster Point Pharm ... | Versant Venture Capital VI, L. ... | 10% Owner | Option Exercise | C | 0.00 | 1,654,359 | 0 | 0 | |
Nov 04 2019 | OYST | Oyster Point Pharm ... | Versant Venture Capital VI, L. ... | 10% Owner | Option Exercise | C | 0.00 | 10,420 | 0 | 0 | |
Nov 04 2019 | OYST | Oyster Point Pharm ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | P | 16.00 | 437,500 | 7,000,000 | 1,003,658 | 566.2 K to 1 M (+77.28 %) |
Nov 04 2019 | OYST | Oyster Point Pharm ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | C | 0.00 | 566,158 | 0 | 566,158 | 0 to 566.2 K |
Nov 04 2019 | OYST | Oyster Point Pharm ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | P | 16.00 | 125,000 | 2,000,000 | 2,561,888 | 2.4 M to 2.6 M (+5.13 %) |
Nov 04 2019 | OYST | Oyster Point Pharm ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | C | 0.00 | 495,388 | 0 | 2,436,888 | 1.9 M to 2.4 M (+25.52 %) |
Nov 04 2019 | OYST | Oyster Point Pharm ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | C | 0.00 | 1,941,500 | 0 | 1,941,500 | 0 to 1.9 M |
Nov 04 2019 | OYST | Oyster Point Pharm ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | P | 16.00 | 27,500 | 440,000 | 2,002,298 | 2 M to 2 M (+1.39 %) |
Nov 04 2019 | OYST | Oyster Point Pharm ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | C | 0.00 | 1,654,359 | 0 | 1,974,798 | 320.4 K to 2 M (+516.28 %) |
Nov 04 2019 | OYST | Oyster Point Pharm ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | C | 0.00 | 10,420 | 0 | 12,438 | 2 K to 12.4 K (+516.35 %) |
Jun 25 2019 | AKRO | Akero Therapeutics ... | Versant Venture Capital VI, L. ... | 10% Owner | Option Exercise | C | 0.00 | 722,737 | 0 | 0 | |
Jun 25 2019 | AKRO | Akero Therapeutics ... | Versant Venture Capital VI, L. ... | 10% Owner | Option Exercise | C | 0.00 | 10,666,667 | 0 | 0 | |
Jun 25 2019 | AKRO | Akero Therapeutics ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | P | 16.00 | 400,000 | 6,400,000 | 4,104,858 | 3.7 M to 4.1 M (+10.80 %) |
Jun 25 2019 | AKRO | Akero Therapeutics ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | C | 0.00 | 235,099 | 0 | 3,704,858 | 3.5 M to 3.7 M (+6.78 %) |
Jun 25 2019 | AKRO | Akero Therapeutics ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | C | 0.00 | 3,469,759 | 0 | 3,469,759 | 0 to 3.5 M |